Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.83 USD | +0.24% | +5.33% | -36.15% |
Business Summary
Number of employees: 7
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joseph Tucker
CEO | Chief Executive Officer | 55 | 21-09-15 |
Kevin Coveney
DFI | Director of Finance/CFO | 60 | 23-03-12 |
Jillian Hagel
CTO | Chief Tech/Sci/R&D Officer | 45 | 21-09-15 |
Peter Facchini
PRN | Corporate Officer/Principal | 60 | 21-09-15 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Webb
CHM | Chairman | 66 | 22-06-12 |
Joseph Tucker
CEO | Chief Executive Officer | 55 | 21-09-15 |
Frank Pasqualone
BRD | Director/Board Member | 68 | 22-07-12 |
George Kegler
BRD | Director/Board Member | 68 | 20-12-29 |
Director/Board Member | 60 | 20-12-29 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 7,752,005 | 7,488,852 ( 96.61 %) | 0 | 96.61 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.15% | 6.05M | |
+64.23% | 62.59B | |
-2.31% | 41.18B | |
+45.55% | 40.29B | |
-8.29% | 27.9B | |
+11.97% | 26.21B | |
-21.16% | 19.09B | |
+7.54% | 13.08B | |
+27.17% | 12.05B | |
+25.72% | 12.26B |
- Stock Market
- Equities
- ENVB Stock
- Company Enveric Biosciences, Inc.